LYEL

Lyell Immunopharma, Inc. - Common Stock (LYEL)

About Lyell Immunopharma, Inc. - Common Stock (LYEL)

Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D. Klausner, Stan Riddell, and Crystal Mackall in June 2018 and is headquartered in South San Francisco, CA.

Details

Daily high

$11.18

Daily low

$10.74

Price at open

$11.02

52 Week High

$45.00

52 Week Low

$10.46

Market cap

269.8M

Dividend yield

Volume

53,686

Avg. volume

114,503

P/E ratio

-.94

Lyell Immunopharma, Inc. - Common Stock News